29 May 2018 - Amid health care tailored to an individual’s DNA, do massive clinical trials that take years and involve thousands of patients still matter?

Sweeping clinical trials in which thousands of patients are studied for years at a stretch have long been the Holy Grail of medical research—especially when funded by the federal government.

But in the era of personalised medicine, where care can be tailored to a person’s genetic make-up and doctors analyse a patient’s DNA to figure out treatments, big trials are falling out of favour.

Read Wall Street Journal article